Teva Pharmaceutical Ownership

TEVJF Stock  USD 17.80  0.45  2.47%   
Teva Pharmaceutical shows a total of 1.11 Billion outstanding shares. About 93.93 % of Teva Pharmaceutical outstanding shares are held by general public with 0.77 (%) owned by insiders and only 5.3 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Teva Pharmaceutical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Teva Pharmaceutical, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

Teva Pink Sheet Ownership Analysis

The company has price-to-book ratio of 1.1. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Teva Pharmaceutical has Price/Earnings To Growth (PEG) ratio of 0.8. The entity recorded a loss per share of 0.56. The firm last dividend was issued on the 28th of November 2017. Teva Pharmaceutical had 2:1 split on the 11th of December 2002. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. TEVA PHARMACEUTICAL is traded on OTC Exchange in the United States.The quote for Teva Pharmaceutical Industries is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Teva Pharmaceutical Industries contact Kare Schultz at 972 3 914 8213 or learn more at https://www.tevapharm.com.

Currently Active Assets on Macroaxis

Other Information on Investing in Teva Pink Sheet

Teva Pharmaceutical financial ratios help investors to determine whether Teva Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teva with respect to the benefits of owning Teva Pharmaceutical security.